DRKS00032584
Completed
Not Applicable
Validation of non-radiative MRI-based multi-atlas attenuation correction for single-photon emission computed tomography - MRI-based attenuation correction for SPECT
niklinik Köln, Klinik für Nuklearmedizin0 sites12 target enrollmentSeptember 26, 2023
ConditionsG20.0
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- G20.0
- Sponsor
- niklinik Köln, Klinik für Nuklearmedizin
- Enrollment
- 12
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Parkinson’s Disease (Hoehn and Yahr \<3\)
- •2\.Participant of the DoMoCo study who previously gave consent that they can be contacted in the future for scientific purpose
- •3\.DAT\-SPECT at the Department of Nuclear Medicine for diagnostic purpose
- •4\.Compatible MRI as part of DoMoCo study
- •5\.Written informed consent
Exclusion Criteria
- •1\.Any radiation exposure in the recent 10 years for scientific or therapy purposes
- •2\.Pregnancy/breast feeding
- •3\.Severe physical illness/physical conditions
- •4\.Claustrophobia or excessive overweight
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The multimodarity imaging assesssment using MRI and US related to the associaton between the skeletal muscle and the liver.JPRN-UMIN000009557niversity of Tsukuba70
Recruiting
Not Applicable
The evalustion of fatty liver disease and post-surgical response in patients undergoing bariatric surgeryKCT0003527Gachon University Gil Medical Center75
Not yet recruiting
Not Applicable
Multicenter MRI for Characterization Of Residual NeuroblasToma after SurgeryC74Malignant neoplasm of adrenal glandDRKS00034345niversitätsklinikum Tübingen
Recruiting
Not Applicable
Validation of Advanced Physiological MR Imaging BiomarkersBrain tumourGlioma10027655NL-OMON55199Erasmus MC, Universitair Medisch Centrum Rotterdam40
Not yet recruiting
Not Applicable
A non-randomised study investigating the use of multiparametric magnetic resonance imaging (mpMRI) to develop imaging biomarkers that will be used to predict treatment response following radiotherapy for prostate cancer.ACTRN12621001118897The University of Auckland10